---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-181938"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2024-07-22T23:59:59+00:00"
generated_at: "2026-05-31T18:27:06.643128+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Jazz reprices $2.7B term loan; margin cut 75 bps to 2.25%+SOFR

## Summary
- Entered Amendment No. 2 to Credit Agreement; Tranche B-2 Dollar Term Loans replace Tranche B-1 at same $2,707,000,000 outstanding.
- Interest margin reduced 75 basis points: new rates are 2.25% (Term SOFR) and 1.25% (prime) vs prior margins.
- Maturity unchanged at May 5, 2028; quarterly amortization of 0.2863% of initial principal; SOFR floor of 0.50% remains.
- Proceeds from new $289.6M additional borrowing used to repay non-converted Tranche B-1 loans; structure includes converting and non-converting lenders.

## SEC filing metadata
- accession: 0001193125-24-181938
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2024-07-22T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312524181938/0001193125-24-181938-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312524181938/d813284d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-181938
- JSON: https://secwatch.observer/filing/0001193125-24-181938.json
- Plain text: https://secwatch.observer/filing/0001193125-24-181938.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.